ClinicalTrials.gg
Not yet recruitingNCT07950566SENSASUpdated Nov 20, 2026

Evaluation of the Reliability of a Wearable Device Combining Inertial Sensors and a Dynamometer for Analyzing Elbow Flexor Spasticity in Patients With Hemiplegia

An interventional study of K-Move/K-Push assessment system in Spasticity, Hemiparesis and Upper Extremity Spasticity, sponsored by University Hospital, Montpellier. Not yet recruiting at 1 site in France. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-11-20.

Sponsored by University Hospital, Montpellier · Not applicable, Interventional, and Other

How we know

Updated Nov 20, 2026Newly registeredGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
40
Allocation
Not applicable
Ages
18 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-21

Among 42 studies in Muscle Spasticity with a site in France — 8 open to participants now, 8 under way, none of them phase 3. Muscle Spasticity · France.

Planned enrollment
18th of 34
40 · median 41
Started
2027
the only one that year
No phase
26 of 42
5 open now
Registered
40th of 42
by date
Lead sponsor
2 of 42
University Hospital, Montpellier

Among the 42 studies in Muscle Spasticity with a site in France, this one is the 18th largest by planned enrollment of the 34 interventional ones that give a count, is the only one that started in 2027, is one of 26 with no phase, and was the 40th registered.

Muscle Spasticity

626 studies on the registry are indexed under Muscle Spasticity; 131 are open to participants now.

Browse Muscle Spasticity studies →

Open to participants now

8 of the 42 studies in Muscle Spasticity with a site in France are open now. Recruiting first, the newest first:

2 more — sign in →

All 8 open studies →

A study can be open while its sites in France have not opened yet or have stopped. Only those recruiting at a site in France →

Who these studies take

Of the 88 Muscle Spasticity studies recruiting now, 29 (33%) set no upper age limit and 47 (53%) stop at 75 or younger; 34 take children under 18; 11 take healthy volunteers.

This study: 18 Years and older · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 42 studies in Muscle Spasticity with a site in France, or all of them as a file.
02

Study summary

SSpasticity is a common motor disorder following central nervous system injury, characterized by a velocity-dependent increase in muscle tone. It affects diverse populations, including patients with stroke, spinal cord injury, multiple sclerosis, or cerebral palsy, and leads to significant functional, pain-related, and medico-economic consequences.

Clinical assessment currently relies on the Modified Tardieu Scale (MTS) and the Modified Ashworth Scale (MAS), whose main limitations are low inter- and intra-rater reproducibility and subjective quantification. Coupling inertial measurement units (IMU) with a portable dynamometer represents a promising instrumental approach to overcome these limitations.

The hypothesis of this pilot clinical investigation is that instrumental measurement combining a portable dynamometer and inertial sensors would achieve satisfactory inter- and intra-rater reproducibility for the assessment of elbow flexor spasticity in patients with unilateral spastic paresis, thereby offering a reliable and objective alternative to current clinical scales.

This project proposes an instrumental assessment of upper-limb spasticity simultaneously combining kinematic measurement (angle, angular velocity) via two K-Move inertial sensors and measurement of resistance force via the K-Push dynamometer (Kinvent, Montpellier), which can easily be used during consultations or at the patient's bedside. This clinical investigation will secondarily assess the feasibility of a kinematic analysis based exclusively on videos acquired by tablet during the instrumental assessment.

03

Conditions studied

  • Spasticity
  • Hemiparesis
  • Upper Extremity Spasticity

Keywords

  • Spasticity
  • Inertial sensor
  • Dynamometer
  • Reproducibility
04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Adult subject
  • Unilateral spastic paresis of the elbow flexors (MTS ≥ 1/4), all etiologies combined
  • Subject hospitalized in the Physical Medicine and Rehabilitation department of Montpellier University Hospital (CHU), undergoing a rehabilitation stay, whether as an inpatient, in a week-hospital, or in a day-hospital setting.

Exclusion criteria

Exclusion Criteria:

  • Subject lacking the cognitive capacity to perform and understand the experimental protocol
  • Subject unable to read and/or write
  • Subject with burns, wounds, abscesses, or any other skin lesion in the area where the devices are to be used
  • Subject with a non-united or healing fracture of the arm, forearm, or wrist of either upper limb
  • Subject with severe osteoporosis or bone fragility considered incompatible with repeated passive mobilizations
  • Pregnant or breastfeeding woman.
  • Absence of free and
  • Subject not affiliated with a social security scheme
  • Subject under a legal protection measure (safeguard of justice, guardianship, curatorship)
  • Subject deprived of liberty by judicial or administrative decision
  • Persons participating in another study with an exclusion period still ongoing.
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Phase
Not applicable
Primary purpose
Other
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
40 participants (estimated)

Study arms

  • Experimental
    Instrumented spasticity assessment

    Adults with unilateral spastic paresis undergoing standardized clinical and instrumental assessment of elbow flexor spasticity using inertial sensors (K-Move), a handheld dynamometer (K-Push), and the Modified Tardieu Scale. Measurements are repeated to evaluate inter-rater and intra-rater reproducibility.

    Device: K-Move/K-Push assessment system

Interventions

  • DeviceK-Move/K-Push assessment system

    Instrumented assessment of elbow flexor spasticity using two wearable inertial sensors (K-Move) synchronized with a handheld dynamometer (K-Push). The system simultaneously records joint angle, angular velocity, and resistance force during passive elbow movements. Measurements are compared with the Modified Tardieu Scale and repeated to assess inter-rater and intra-rater reproducibility.

06

What researchers measure

Primary outcomes

  1. Inter-rater and intra-rater reproducibility of instrumental measurement for elbow flexor spasticity assessment

    Reproducibility of biomechanical parameters obtained from the instrumental measurement combining two inertial sensors (K-Move) and a portable dynamometer (K-Push) during passive elbow extension at three stretch velocities (slow, intermediate, and fast). Parameters include total elbow extension range of motion (in degrees), mean stretch velocity (in meters per second, m/s), angle of onset of spasticity (in degrees), referred to as the "catch", maximum resistance force measured by the dynamometer (in Newtons), mean resistance force measured by the dynamometer (in Newtons) over the entire movement, and extent of spastic resistance defined as the range of motion over which the resistance persists (in degrees). Inter-rater reproducibility will be assessed between two independent raters on Day 1, and intra-rater reproducibility will be assessed by repeated measurements performed by the same rater between Day 1 and Day 2.

    Time frame: Day 1 and Day 2

Secondary outcomes

  1. Difference in total elbow range of motion between the affected and unaffected upper limbs

    Comparison of the total elbow extension range of motion (in degrees) of the affected limb and the unaffected controlateral limb, measured with the instrumental measurement combining two initial sensors (K-Move) and a portable dynamometer (K-Push) during passive elbow extension at three stretch velocities (slow, intermediate, and fast), measured in real time

    Time frame: Day 1

  2. Difference in the mean stretch velocity between the affected and unaffected upper limbs

    Comparison of the mean stretch velocity (in meters per second, m/s) of the affected limb and the unaffected controlateral limb, measured with the instrumental measurement combining two initial sensors (K-Move) and a portable dynamometer (K-Push) during passive elbow extension at three stretch velocities (slow, intermediate, and fast), measured in real time

    Time frame: Day 1

  3. Difference in the maximum resistance force between the affected and unaffected upper limbs

    Comparison of the maximum resistance force measured by the dynamometer (in Newtons) of the affected limb and the unaffected controlateral limb, measured with the instrumental measurement combining two initial sensors (K-Move) and a portable dynamometer (K-Push) during passive elbow extension at three stretch velocities (slow, intermediate, and fast), measured in real time

    Time frame: Day 1

  4. Difference in the mean resistance force between the affected and unaffected upper limbs

    Comparison of the mean resistance force measured by the dynamometer (in Newtons) over the entire movement of the affected limb and the unaffected controlateral limb, measured with the instrumental measurement combining two initial sensors (K-Move) and a portable dynamometer (K-Push) during passive elbow extension at three stretch velocities (slow, intermediate, and fast), measured in real time

    Time frame: Day 1

  5. Difference in the extend of spastic resistance between the affected and unaffected upper limbs

    Comparison of the extend of spastic resistance defined as the range of motion over which the resistance persists (in degrees) of the affected limb and the unaffected controlateral limb, measured with the instrumental measurement combining two initial sensors (K-Move) and a portable dynamometer (K-Push) during passive elbow extension at three stretch velocities (slow, intermediate, and fast), measured in real time

    Time frame: Day 1

  6. Comparison of Instrumental and Clinical Measures of total elbow range of motion

    Total elbow extension range of motion (in degrees) of the affected limb measured with the instrumental measurement combining two initial sensors (K-Move) and a portable dynamometer (K-Push) during passive elbow extension at three stretch velocities (slow, intermediate, and fast) measured in real time. Measured angle (in degrees) measured on the affected limb during the clinical assessment of spasticity using the Modified Tardieu Scale

    Time frame: Day 1

  7. Comparison of Instrumental and Clinical Measures of stretch velocity

    Mean stretch velocity (in meters per second, m/s) of the affected limb measured with the instrumental measurement combining two initial sensors (K-Move) and a portable dynamometer (K-Push) during passive elbow extension at three stretch velocities (slow, intermediate, and fast) measured in real time. Stretch velocity categorized as slow, medium or fast, measured on the affected limb during the clinical assessment of spasticity using the Modified Tardieu Scale

    Time frame: Day 1

  8. Comparison of Instrumental Resistance Force and Clinical Spasticity Assessment

    Mean resistance force measured by the dynamometer (in Newtons) over the entire movement of the affected limb measured with the instrumental measurement combining two initial sensors (K-Move) and a portable dynamometer (K-Push) during passive elbow extension at three stretch velocities (slow, intermediate, and fast) measured in real time. Modified Tardieu Scale Assessment, from 0 to 4, measured on the affected limb during the clinical assessment of spasticity using the Modified Tardieu Scale The Modified Tardieu Scale grade ranges from 0 to 4, where 0 indicates no resistance during passive movement and 4 indicates sustained clonus lasting more than 10 seconds. Higher scores indicate a more pronounced muscle reaction to fast passive stretch.

    Time frame: Day 1

  9. Comparison of Instrumental extend of spastic resistance and Clinical Spasticity Assessment

    Extend of spastic resistance defined as the range of motion over which the resistance persists (in degrees) of the affected limb measured with the instrumental measurement combining two initial sensors (K-Move) and a portable dynamometer (K-Push) during passive elbow extension at three stretch velocities (slow, intermediate, and fast) measured in real time. Modified Tardieu Scale Assessment, from 0 to 4, measured on the affected limb during the clinical assessment of spasticity using the Modified Tardieu Scale The Modified Tardieu Scale grade ranges from 0 to 4, where 0 indicates no resistance during passive movement and 4 indicates sustained clonus lasting more than 10 seconds. Higher scores indicate a more pronounced muscle reaction to fast passive stretch.

    Time frame: Day 1

  10. Duration of instrumental measurement compared with Modified Tardieu Scale assessment

    Comparison of the administration time required to perform the instrumental assessment using inertial sensors and a dynamometer versus the clinical assessment using the Modified Tardieu Scale. Time will be recorded in minutes and seconds.

    Time frame: Day 1

  11. Feasibility of post hoc biomechanical parameter extraction from video recordings

    Feasibility of extracting biomechanical parameters from synchronized video recordings acquired during instrumental assessment using predefined image quality and joint landmark visibility criteria. Feasibility will be determined by the proportion of participants for whom video-based biomechanical analysis can be successfully performed.

    Time frame: Day 1

  12. Comparison of Video-Derived and Instrumental total range of motion

    Comparison of the total elbow extension range of motion (in degrees) obtained through real-time instrumental measurement using two initial sensors (K-Move) combined with a portable dynamometer (K-Push), and retrospective measurement through video analysis, during passive elbow extension of the affected limb at three stretch velocities (slow, intermediate, and fast).

    Time frame: Day 1

  13. Comparison of Video-Derived and Instrumental mean stretch velocity

    Comparison of mean stretch velocity (in meters per second, m/s) obtained through real-time instrumental measurement using two initial sensors (K-Move) combined with a portable dynamometer (K-Push), and retrospective measurement through video analysis, during passive elbow extension of the affected limb at three stretch velocities (slow, intermediate, and fast).

    Time frame: Day 1

  14. Comparison of Video-Derived and Instrumental maximum resistance force

    Comparison of the maximum resistance force measured by the dynamometer (in Newtons) obtained through real-time instrumental measurement using two initial sensors (K-Move) combined with a portable dynamometer (K-Push), and retrospective measurement through video analysis, during passive elbow extension of the affected limb at three stretch velocities (slow, intermediate, and fast).

    Time frame: Day 1

  15. Comparison of Video-Derived and Instrumental total range of mean resistance force

    Comparison of the mean resistance force measured by the dynamometer (in Newtons) over the entire movement obtained through real-time instrumental measurement using two initial sensors (K-Move) combined with a portable dynamometer (K-Push), and retrospective measurement through video analysis, during passive elbow extension of the affected limb at three stretch velocities (slow, intermediate, and fast).

    Time frame: Day 1

  16. Comparison of Video-Derived and Instrumental total range of extend of spastic resistance

    Comparison of the extend of spastic resistance defined as the range of motion over which the resistance persists (in degrees) obtained through real-time instrumental measurement using two initial sensors (K-Move) combined with a portable dynamometer (K-Push), and retrospective measurement through video analysis, during passive elbow extension of the affected limb at three stretch velocities (slow, intermediate, and fast).

    Time frame: Day 1

  17. Comparison of Video-Derived and Clinical Measures of total range of motion

    Total elbow extension range of motion (in degrees) of the affected limb measured with the instrumental measurement combining two initial sensors (K-Move) and a portable dynamometer (K-Push) during passive elbow extension at three stretch velocities (slow, intermediate, and fast) measured retrospectively through video analysis Measured angle (in degrees) measured on the affected limb during the clinical assessment of spasticity using the Modified Tardieu Scale

    Time frame: Day 1

  18. Comparison of Video-Derived and Clinical Measures of stretch velocity

    Mean stretch velocity (in meters per second, m/s) of the affected limb measured with the instrumental measurement combining two initial sensors (K-Move) and a portable dynamometer (K-Push) during passive elbow extension at three stretch velocities (slow, intermediate, and fast) measured retrospectively through video analysis Stretch velocity categorized as slow, medium or fast, measured on the affected limb during the clinical assessment of spasticity using the Modified Tardieu Scale

    Time frame: Day 1

  19. Comparison of Video-Derived and Clinical Measures of extend of spastic resistance

    Extend of spastic resistance defined as the range of motion over which the resistance persists (in degrees) of the affected limb measured with the instrumental measurement combining two initial sensors (K-Move) and a portable dynamometer (K-Push) during passive elbow extension at three stretch velocities (slow, intermediate, and fast) measured retrospectively through video analysis Modified Tardieu Scale Assessment, from 0 to 4, measured on the affected limb during the clinical assessment of spasticity using the Modified Tardieu Scale The Modified Tardieu Scale grade ranges from 0 to 4, where 0 indicates no resistance during passive movement and 4 indicates sustained clonus lasting more than 10 seconds. Higher scores indicate a more pronounced muscle reaction to fast passive stretch.

    Time frame: Day 1

  20. Comparison of Video-Derived and Clinical Resistance Force Measurements

    Mean resistance force measured by the dynamometer (in Newtons) over the entire movement of the affected limb measured with the instrumental measurement combining two initial sensors (K-Move) and a portable dynamometer (K-Push) during passive elbow extension at three stretch velocities (slow, intermediate, and fast) measured retrospectively through video analysis Modified Tardieu Scale Assessment, from 0 to 4, measured on the affected limb during the clinical assessment of spasticity using the Modified Tardieu Scale The Modified Tardieu Scale grade ranges from 0 to 4, where 0 indicates no resistance during passive movement and 4 indicates sustained clonus lasting more than 10 seconds. Higher scores indicate a more pronounced muscle reaction to fast passive stretch.

    Time frame: Day 1

07

Study locations

1 site
08

References and documents

Individual participant data

Plan to share: Undecided

No publications or documents are linked to this record.

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Start is estimated for Feb 2027; primary completion for Feb 2029, 24 months later.

Of 227 non-industry interventional studies with no phase under Muscle Spasticity, half reached primary completion within 15 months of starting (the median), counting those still running; a quarter within 6 and three quarters within 34. This study's planned 24 months is above that.

Counting every sponsor, half of 235 studies reached it within 15 months; a quarter within 7 and three quarters within 32.

How these figures are worked out, and which studies are left out of them.

Registered
Aug 25, 2026
First posted
Nov 20, 2026
StartEst.
Feb 2027
Primary completionEst.
Feb 2029
CompletionEst.
Feb 2029
Last update
Nov 20, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Registered
First appeared on the registry. No changes since
Nov 20, 2026
Show all 1 update
  1. Nov 20, 2026
    First appeared on the registry

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07950566
Responsible party
Sponsor
First posted
Nov 20, 2026
Start date
Feb 2027 (estimated)
Primary completion
Feb 2029 (estimated)
Completion
Feb 2029 (estimated)
Last update
Nov 20, 2026

Study contacts

Eva Tamburro, MD
Contact
e-tamburro@chu-montpellier.fr
06 95 16 61 97 ext. 33
Eva Tamburro, MD
principal investigator · University Hospital, Montpellier

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Nov 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion